Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 16, 2010 08:00 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma, Inc. to Present at the 4th Annual Maxim Group Growth Conference

PHILADELPHIA, Nov. 16, 2010 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company"), an advanced specialty pharmaceutical company engaged in the clinical development of new drug...
November 11, 2010 08:00 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma, Inc. to Discuss Third Quarter Results of Operations on Tuesday, November 16, 2010

PHILADELPHIA, Nov. 11, 2010 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company"), an advanced specialty pharmaceutical company engaged in the clinical development of new drug...
November 10, 2010 08:00 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma Receives Therapeutic Discovery Project Grant From U.S. Department of Treasury

PHILADELPHIA, Nov. 10, 2010 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) announced today grant awards totaling $488,958 from the U.S. Department of Treasury in support of its...
November 08, 2010 16:49 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma, Inc. 3rd Quarter 2010 Financial Results

PHILADELPHIA, Nov. 8, 2010 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) announced its financial results for the three months ended September 30, 2010. The net loss (including...
September 08, 2010 16:46 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma to Present at the Rodman and Renshaw 12th Annual Healthcare Conference

PHILADELPHIA, Sept. 8, 2010 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company"), today announced that the Company will participate in the Rodman & Renshaw 12th Annual...
September 08, 2010 10:23 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma to Present New Retrovirus (XMRV) Data at 1st International Workshop on XMRV and Chronic Fatigue Syndrome (CFS)

BETHESDA, Md., Sept. 8, 2010 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) will present new clinical data on the possible inter-relationships of XMRV positivity/chronic fatigue...
August 24, 2010 08:00 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Settles All Securities Class Actions

PHILADELPHIA, Aug. 24, 2010 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) today announced that, as result of court mediation proceedings, it has entered into a written agreement in...
August 18, 2010 08:00 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma Awarded $188 Million Judgment Against JCI

PHILADELPHIA, Aug. 18, 2010 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) today announced that its six-year litigation battle with the South African investment conglomerate JCI Ltd.,...
August 06, 2010 15:16 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma, Inc. 2nd Quarter 2010 Financial Results

PHILADELPHIA, Aug. 6, 2010 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) announced its financial results for the three months ended June 30, 2010. The net loss (including non-cash...
July 19, 2010 08:00 ET | Source: Hemispherx Biopharma, Inc.

The Indian Drugs Controller General Approves Start of Clinical Study of Hemispherx Biopharma's Natural Interferon Product, Alferon N Injection(R), in Hospitalized Flu Patients

PHILADELPHIA, July 19, 2010 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB), an advanced specialty pharmaceutical company engaged in the clinical development of new drug entities for...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right